Salvage surgery for advanced non-small cell lung cancer after response to gefitinib

Journal of Thoracic and Cardiovascular Surgery

Volumn 140, Issue 5, 2010, Pages

  Hishida, Tomoyuki ^a   Nagai, Kanji ^a   Mitsudomi, Tetsuya ^b   Yokoi, Kohei ^c   Kondo, Haruhiko ^d   Horinouchi, Hirohisa ^e   Akiyama, Hirohiko ^f   Nagayasu, Takeshi ^g   Tsuboi, Masahiro ^h  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d SHIZUOKA CANCER CENTER   (Japan)

^e KEIO UNIVERSITY   (Japan)

^f SAITAMA CANCER CENTER   (Japan)

^g NAGASAKI UNIVERSITY   (Japan)

^h KANAGAWA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; GEFITINIB; GEMCITABINE; NAVELBINE; PACLITAXEL; TEGAFUR; ANTINEOPLASTIC AGENT; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN KINASE INHIBITOR; QUINAZOLINE DERIVATIVE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; MUTATIONAL ANALYSIS; OVERALL SURVIVAL; PATIENT SAFETY; PRIORITY JOURNAL; SALVAGE THERAPY; TREATMENT RESPONSE; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE FREE SURVIVAL; GENETICS; JAPAN; KAPLAN MEIER METHOD; LUNG NEOPLASMS; LUNG RESECTION; MIDDLE AGED; MORTALITY; MUTATION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PATHOLOGY; SECONDARY; TIME; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; JAPAN; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PNEUMONECTOMY; PROTEIN KINASE INHIBITORS; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SALVAGE THERAPY; TIME FACTORS; TREATMENT OUTCOME; KAPLAN-MEIER ESTIMATE;

EID: 77958008388     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2010.06.035     Document Type: Article

References (5)

1. T.S. Mok, Y.L. Wu, S. Thongprasert, C.H. Yang, D.T. Chu, and N. Saijo Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma N Engl J Med 361 2009 947 957
2. K. Takamochi, K. Suzuki, H. Sugimura, K. Funai, H. Mori, and A.H. Bashar Surgical resection after gefitinib treatment in patients with lung adenocarcinoma harboring epidermal growth factor receptor gene mutation Lung Cancer 58 2007 149 155
3. I. Kappers, H.M. Klomp, J.A. Burgers, N. Van Zandwijk, R.L. Haas, and R. van Pel Neoadjuvant (induction) erlotinib response in stage IIIA non-small-cell lung cancer J Clin Oncol 26 2008 4205 4207
4. E.V. Levchenko, V.M. Moiseyenko, D.E. Matsko, A.G. Iyevleva, A.O. Ivantsov, and S.M. Yargnian Down-staging of EGFR mutation-positive advanced lung carcinoma with gefitinib followed by surgical intervention: follow-up of two cases Onkologie 32 2009 674 677
5. H. Lara-Guerra, T.K. Waddell, M.A. Salvarrey, A.M. Joshua, C.T. Chung, and N. Paul Phase II study of preoperative gefitinib in clinical stage I non-small-cell lung cancer J Clin Oncol 27 36 2009 6229 6236